PENTAXIM (one-dose booster): Clinical Trials

1 trial of PENTAXIM (one-dose booster), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow PENTAXIM (one-dose booster): new trials by email Literature Review of PENTAXIM (one-dose booster) trials Research Report on PENTAXIM (one-dose booster)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
DTacP (one-dose booster), DTacP (three-dose primary vaccination), DT (one-dose booster) - Diphtheria, Tetanus
Phase 1RecruitingInstitute of Medical Biology, Chinese Academy of Medical Sciences4602023-12-232024-01-03

Conditions studied

Diphtheria (1)  ·  Tetanus (1)  ·  Whooping Cough (1)

Sponsors

Institute of Medical Biology, Chinese Academy of Medical Sciences (1)

Countries

China (1)